Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 35.29 USD 0.14% Market Closed
Market Cap: 5.6B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+20%
Revenue
Forecast
+8%
Operating Income
Forecast
+9%
Net Income
Forecast
+13%

Wall Street
Price Targets

IONS Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast IONS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IONS is 58.71 USD with a low forecast of 37.37 USD and a high forecast of 87.15 USD.

IONS Lowest Forecast
Wall Street Target
37.37 USD
6% Upside
IONS Average Forecast
Wall Street Target
58.71 USD
66% Upside
IONS Highest Forecast
Wall Street Target
87.15 USD
147% Upside
Lowest
Price Target
37.37 USD
6% Upside
Average
Price Target
58.71 USD
66% Upside
Highest
Price Target
87.15 USD
147% Upside
Ionis Pharmaceuticals Inc Competitors:
Price Targets
300685
Amoy Diagnostics Co Ltd
47% Upside
SLNO
Soleno Therapeutics Inc
45% Upside
EXAS
Exact Sciences Corp
29% Upside
LTRN
Lantern Pharma Inc.
576% Upside
300685
Amoy Diagnostics Co Ltd
47% Upside
SLNO
Soleno Therapeutics Inc
45% Upside
EXAS
Exact Sciences Corp
29% Upside
LTRN
Lantern Pharma Inc.
576% Upside
BRNS
Barinthus Biotherapeutics PLC
361% Upside
IGMS
IGM Biosciences Inc
50% Upside
RCKT
Rocket Pharmaceuticals Inc
409% Upside
688331
RemeGen Co Ltd
24% Downside

Revenue
Forecast

Revenue Estimate
Ionis Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 8%. The projected CAGR for the next 3 years is 20%.

8%
Past Growth
20%
Estimated Growth
Estimates Accuracy
10%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
What are analyst estimates?

See Also

Summary
IONS intrinsic value, competitors valuation, and company profile.
DCF Valuation
IONS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IONS stock valuation using valuation multiples.
Wall Street Estimates
IONS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IONS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IONS's stock price target?
Price Target
58.71 USD

According to Wall Street analysts, the average 1-year price target for IONS is 58.71 USD with a low forecast of 37.37 USD and a high forecast of 87.15 USD.

What is Ionis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 8%. The projected CAGR for the next 3 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.